Jain A et al. |
Prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone, and mycophenolate mofetil: complete report on 350 primary adult liver transplantations. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267319
|
Mueller AR et al. |
Influence of immunosuppression on patient survival after liver transplantation for hepatitis C. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267321
|
Mohamed MA et al. |
TGF-beta expression in protocol transplant liver biopsies: a comparative study between cyclosporine-A (CyA) and tacrolimus (FK 506) immunosuppression. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267336
|
Shokouh-Amiri MH et al. |
The importance of early prevention of renal dysfunction in liver transplant recipients. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267345
|
Markus BH et al. |
Daclizumab induction therapy in combination with tacrolimus. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267354
|
Langrehr JM et al. |
IL-2 receptor antibody induction increases the risk for chronic rejection after liver transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267360
|
Heffron TG et al. |
Single-dose induction with daclizumab immediately after liver transplantation in pediatric patients. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267368
|
Groetzner J et al. |
Tacrolimus or cyclosporine for immunosuppression after cardiac transplantation: which treatment reveals more side effects during long-term follow-up? |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267373
|
van den Berg AP et al. |
Recurrent HCV infection reduces the requirement for tacrolimus after liver transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267375
|
Pirenne J et al. |
Standard cyclosporine A-based versus completely steroid-free FK506-based immunosuppression after liver transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267396
|
Langrehr JM et al. |
A prospective, randomized trial with quadruple versus dual tacrolimus-based induction after liver transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267404
|
Heffron TG et al. |
Daclizumab induction in liver transplant recipients. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267408
|
Rabkin JM et al. |
Pharmacoeconomic study of tacrolimus-based versus cyclosporine-based immunosuppressive therapy following liver transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267411
|
Uber PA et al. |
Ethnic disparities in the pharmacologic characteristics of tacrolimus in heart transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267428
|
Banerjee R et al. |
Coadministration of itraconazole and tacrolimus after thoracic organ transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267435
|
Mehra MR et al. |
A randomized comparison of an immunosuppressive strategy using tacrolimus and cyclosporine in black heart transplant recipients. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267438
|
Mehra MR et al. |
Racial differences in clinical outcome using tacrolimus and mycophenolate mofetil immunosuppression in heart transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267442
|
Treede H et al. |
Incidence and spectrum of infections in lung transplanted patients: comparison of four different immunosuppressive protocols. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267444
|
Jordan ML et al. |
Steroid withdrawal for pancreas transplants under tacrolimus immunosuppression. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267456
|
Lo A et al. |
Outcome of simultaneous kidney-pancreas transplantation in African-American recipients: a case control study. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267465
|
Burke GW et al. |
Ten-year survival after simultaneous pancreas/kidney transplantation with bladder drainage and tacrolimus-based immunosuppression. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267467
|
Kahl A et al. |
Long-term prednisolone withdrawal after pancreas and kidney transplantation in patients treated with ATG, tacrolimus, and mycophenolate mofetil. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267473
|
McCauley J et al. |
Long-term lipid metabolism in combined kidney-pancreas transplant recipients under tacrolimus immunosuppression. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267475
|
Lo A et al. |
Limited benefits of induction with monoclonal antibody to interleukin-2 receptor in combination with tacrolimus, mycophenolate mofetil, and steroids in simultaneous kidney-pancreas transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267477
|
Owen ER et al. |
Peripheral nerve regeneration in human hand transplantation. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267484
|
Molmenti EP et al. |
Incidence, management, and outcome of posttransplant lymphoproliferative disease in pediatric liver transplant recipients. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267487
|
Spada M et al. |
A cause of late graft dysfunction after liver transplantation in children: de-novo autoimmune hepatitis. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267495
|
Lo A et al. |
Ganciclovir prophylaxis for cytomegalovirus infection in simultaneous kidney-pancreas transplant recipients receiving tacrolimus, mycophenolate mofetil, and prednisone. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267516
|
Reimer J et al. |
Quality of life after kidney transplantation--the impact of tacrolimus. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267573
|
Jain A et al. |
Pharmacokinetics of mycophenolic acid after mycophenolate mofetil administration in liver transplant patients treated with tacrolimus. |
2001 |
J Clin Pharmacol |
pmid:11269567
|
Bekersky I et al. |
Effect of time of meal consumption on bioavailability of a single oral 5 mg tacrolimus dose. |
2001 |
J Clin Pharmacol |
pmid:11269569
|
Ericzon B et al. |
Glucose metabolism in liver transplant recipients treated with FK 506 or cyclosporin in the European multicentre study. |
1994 |
Transpl. Int. |
pmid:11271178
|
Undre N and Möller A |
Pharmacokinetic interpretation of FK 506 levels in blood and in plasma during a European randomised study in primary liver transplant patients. The FK 506 European Study Group. |
1994 |
Transpl. Int. |
pmid:11271189
|
Yano K et al. |
Effects of intrahepatic arterial and intraportal administration of FK 506 on liver allograft survival in rats. |
1994 |
Transpl. Int. |
pmid:11271200
|
Devlin J et al. |
Renal complications and development of hypertension in the European study of FK 506 and cyclosporin in primary liver transplant recipients. |
1994 |
Transpl. Int. |
pmid:11271207
|
|
Two-year follow-up study of the efficacy and safety of FK 506 in kidney transplant patients. Japanese FK 506 Study Group. |
1994 |
Transpl. Int. |
pmid:11271216
|
Neuhaus P et al. |
Neurological complications in the European multicentre study of FK 506 and cyclosporin in primary liver transplantation. |
1994 |
Transpl. Int. |
pmid:11271222
|
Bismuth H et al. |
Focus on intractable rejection: 6-month results of the European multicentre liver study of FK 506 and cyclosporin A. |
1994 |
Transpl. Int. |
pmid:11271231
|
McMaster P |
Patient and graft survival in the European Multicentre Liver Study--FK 506 vs cyclosporin A. |
1994 |
Transpl. Int. |
pmid:11271239
|
Mueller AR et al. |
Neurotoxicity after orthotopic liver transplantation in cyclosporin A- and FK 506-treated patients. |
1994 |
Transpl. Int. |
pmid:11271254
|
D'Silva M et al. |
The immunomodulatory effects of a novel agent, leflunomide, in rat cardiac allotransplantation. |
1994 |
Transpl. Int. |
pmid:11271257
|
Trocha K et al. |
Neurological examinations after liver transplantation concerning patients under corticosteroid immunosuppression and either FK 506 or cyclosporin. |
1994 |
Transpl. Int. |
pmid:11271273
|
Ishii T et al. |
Immunodepressants ameliorate normothermic ischemia injury to the rat liver by down-regulating tumor necrosis factor, not by alleviation of lipid peroxidative injury. |
1994 |
Transpl. Int. |
pmid:11271294
|
Platz KP et al. |
Nephrotoxicity after orthotopic liver transplantation in cyclosporin A and FK 506-treated patients. |
1994 |
Transpl. Int. |
pmid:11271297
|
Metcalfe S et al. |
FK 506 and cyclosporin each block antigen-induced T cell receptor signalling that is dependent on CD4 co-receptor and operates in the absence of detectable cytoplasmic calcium fluxes. |
1994 |
Transpl. Int. |
pmid:11271304
|
Moutabarrik A et al. |
Effect of immunosuppressive agents FK 506 and cyclosporin and steroids on the expression of IL-6 and its receptor by stimulated lymphocytes and monocytes. |
1994 |
Transpl. Int. |
pmid:11271305
|
Winkler M et al. |
Optimal FK 506 dosage in patients under primary immunosuppression following liver transplantation. |
1994 |
Transpl. Int. |
pmid:11271312
|
Devlin J et al. |
FK 506 primary immunosuppression following emergency liver transplantation for fulminant hepatic failure. European FK 506 Study Liver Group. |
1994 |
Transpl. Int. |
pmid:11271328
|
Otto G et al. |
Corticosteroids and concomitant medication in the European multicentre study of FK 506 and cyclosporin in primary liver transplantation. |
1994 |
Transpl. Int. |
pmid:11271338
|
Wong P et al. |
FK 506 rescue therapy for intractable liver allograft rejection. |
1994 |
Transpl. Int. |
pmid:11271339
|